Haem biosynthesis appeared to be a target of malaria therapy because 5-aminolevulinic acid (ALA), a haem biosynthesis starting material, with light exposure or a high amount of ALA alone reduced Plasmodium falciparum growth to undetectable level. However, the administration of a high dose of ALA is unrealistic for clinical therapy. We found that Fe 2þ enhanced P. falciparum-killing potency of ALA and significantly inhibited the parasite growth. The intermediates of haem biosynthesis localized to the parasite organelles, and coproporphyrin III was the most accumulated intermediate. These novel findings may lead to development of a new anti-malarial drug using ALA and Fe 2þ .
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Malaria is a major global health problem, truncating over 1 million human lives annually, mainly children in the tropical and sub-tropical regions (1) . The most lethal species of pathogens is Plasmodium falciparum, transmitted by the female Anopheles mosquitoes. They invade the hepatocytes first and differentiate into merozoites, which are released to infect red blood cells (RBCs) and establish the disease (2) . The erythrocytic cycle is composed of the following stages: ring (early infection form), trophozoite (mature and undergo asexual division) and schizont (which ruptures RBCs and the resulting merozoites proceed to infect new RBCs). Due to difficulties in anti-malarial vaccine development, it is pertinent to rely on chemotherapy to control malaria. However, the parasites are able to rapidly develop resistance against the available chemotherapies (3). Hence, new drugs with different modes of action are urgently needed. Enzymes in the pathways of macromolecular and metabolite biosynthesis such as haem production and degradation, have been recognized as novel chemotherapeutic targets in the Plasmodium (49).
Haem is an iron-containing complex macrocycle that plays a fundamental role in many cellular processes including oxygen transport (haemoglobin) and storage (myoglobin), mitochondrial electron transport complexes and detoxification (cytochrome) (10) . Mitochondrion is an important organelle of the parasite, where Haem-containing proteins are necessary for its functions (11, 12) . Since atovaquone, an antimalarial drug, specifically targets complex III (cytochrome bc 1 ) in Plasmodium, mitochondrial respiration must be fundamental for the parasite survival (13) . Recent studies revealed that Plasmodium possesses de novo Haem synthesis and it plays an essential role in the mosquito and liver stages (7) . Interestingly, the parasite does not salvage haem but rather polymerize Haems from host haemoglobin into haemozoin, as a mechanism of detoxification in its food vacuole to prevent production of reactive oxygen species (ROS) by free haem (14) . This system is well known as the target of anti-malarial drug, chloroquine (6) .
Generally in non-photosynthetic eukaryotes, haem biosynthesis starts with formation of 5-aminolevulinic acid (ALA) via the Shemin pathway, which involved condensation of glycine and succinyl-CoA (15) . In mammalian cells, this step is catalysed by ALA synthase in the mitochondria. Next five steps in the cytosol and two final steps in the mitochondria take place, respectively. As shown in Supplementary Fig. S1 , apicoplast, an additional compartment of Plasmodium, houses four haem synthesis enzymes (9) . The last two enzymes, protoporphyrinogen IX oxidase and ferrochelatase (FC) are localized in the mitochondria.
In cancer cells, their uptake of a high concentration of ALA results in elevated levels of the metabolites particularly PPIX because of insufficient activity of FC (1619). This accumulation of PPIX and other intermediates have led to the development of photodynamic diagnosis (PDD) and photodynamic therapy (PDT) of cancer. The principle behind the PDT rests on PPIX as a photosensitizer releasing singlet oxygen and other ROS leading to extensive cellular damages and cell death (20, 21) . Smith and Kain (2004) tried PDT to malaria parasites by ALA (17) . Indeed, the growth of P. falciparum in blood culture was completely inhibited by 0.2 mM ALA followed by exposure to white light or by a higher concentration (2 mM) of ALA alone without light exposure. Unfortunately, direct adoption of ALA-PDT to malaria patient treatment is clinically unrealistic. However, in the present study, we found this pathway to be an attractive and promising target of malaria chemotherapy when ALA is supplemented with sodium ferrous citrate (SFC).
Plasmodium falciparum 3D7 strain was cultured and synchronous ring form was obtained as described previously (22) . The haem intermediates were determined by HPLC according to the methods previously reported (23) . Acyl carrier protein (ACP), the apicoplast marker, fused with GFP was used to locate the apicoplast (24, 25) . Details of the experimental procedures including organelle separation (26) are described in 'Supplementary Information'.
After extensive search of the previous reports on haem metabolism in Plasmodium, we studied effects of metal ions on the growth inhibition by ALA using human malaria parasite, P. falciparum 3D7. In fact, there was a report on protection from malaria by elevated zinc protoporphyrin, which binds to haem crystals to inhibit further crystallization to form haemozoin (27) . In the first screening, iron was not examined because malaria infection impacts iron metabolism of the host in many diverse ways and debate on the effect of iron supplementation is still not clear (14) . As shown in Fig. 1A , 10 mM CoCl 2 and CuCl 2 inhibited P. falciparum growth, while MgCl 2 , NiCl 2 , ZnCl 2 and Pb(NO 3 ) 2 did not show growth inhibition. However, in the presence of 200 mM of ALA, no significant difference from the experiments without ALA was observed, indicating that CoCl 2 and CuCl 2 do not synergistically enhance anti-malarial activity of ALA. Since none of those metal ions tested enhanced the growth inhibition of ALA, the effect of iron was examined next. Interestingly, the growth inhibition was increased to more than 50% when infected cells were treated with 10 mM SFC and 200 mM ALA, although SFC alone did not show any effect (Fig. 1A) . The growth inhibition of the parasite by either ALA or SFC was dose-dependent ( Supplementary Fig. S2 ). Similar effect was observed with FeCl 2 and FeSO 4 (data not shown). In contrast, oxidized iron such as ferric ammonium citrate, FeCl 3 and iron pyrophosphate did not inhibit the growth even in the presence of ALA, suggesting that only ferrous compounds have ability for synergy on ALA.
To determine haem intermediates, the cell extract of the parasites obtained from culture was analysed by HPLC. As shown in Fig. 1B , the extract contained three major intermediates coproporphyrin I (CPI), coproporphyrin III (CPIII) and protoporphyrin IX (PPIX). CPIII was the most accumulated intermediate in P. falciparum (Fig. 1C) . Accumulation of the haem intermediates was independent of SFC concentration after 24 h of ALA/SFC treatment ( Supplementary Fig.  S3 ) indicating that the combination of porphyrin accumulation and Fe 2þ is required for the growth inhibition.
As the haem intermediates, including uroporphyrin III, CPIII, PPIX, are detectable by red fluorescence light, localization of the intermediates in the parasite treated with ALA and SFC was examined ( Fig. 2A) . In ring stage, the haem intermediates co-localized with GFP fused with ACP, which is an apicoplast marker (upper panel). In contrast, the haem intermediates colocalized with haemozoin in trophozoite and schizont stages (middle and lower panels), suggesting that the haem intermediates were localized to food vacuole at these stages.
To further confirm the localization of the intermediates in the organelles, fractions obtained by Percoll density gradient centrifugation after disruption of the cells by N 2 -cavitation (26) were analysed (Fig. 2B) . CPIII was predominantly accumulated in apicoplasts separated in the top fractions (2 and 3). PPIX was found in mitochondria (79). CPI, CPIII and PPIX were accumulated in the food vacuole, which contains haemozoin (2123 in Supplementary Fig. S4A ). CPIII and PPIX were accumulated in the RBC cytosol and medium, whereas only CPIII was accumulated in the parasite cytosol (Supplementary Fig. S4B ). These results are consistent with the fluorescence microscopy observation except mitochondrial PPIX that was not detected by fluorescence microscopy due to relatively small amounts compared with CPIII.
The results presented here clearly show the growth inhibition of the malaria parasite by ALA/ Fe 2þ without light irradiation. However, mechanism of the growth inhibition is still unclear. One interesting result obtained is the suppression of ALA/Fe 2þ growth inhibition of P. falciparum by ascorbate, a well-known anti-oxidant agent (Supplementary Fig. S5 ). Antioxidant effect of ascorbate suppressed growth inhibition of P. falciparum by ROS has been reported although N-acetyl-L-cysteine is weaker than ascorbate (28) . Moreover, significant ROS production was observed by using 3-p-aminophenyl fluorescein (APF) in the parasites treated with ALA/Fe 2þ (Supplementary Fig. S6 ). Since both low pH (lower than pH 3.0) and enough oxygen are essential for the Fenton reaction of iron with ascorbate (29, 30) , it is unlikely to occur with ascorbate in the parasite at neutral pH in the cytoplasm and low oxygen tension (5%) in the culture. In this regard, the synergy with ferrous but not ferric ion is quite interesting because iron has been discussed as a double-edged sword in the treatment of malaria patients (14) . Exacerbation of malaria by iron supplement has been reported while an iron chelator, desferrioxamine, reduces the anti-malarial action of artemisinin. Similar to artemisinin, which is activated by Fenton reaction and produces ROS (31), the haem intermediates may interact with Fe 2þ transported into the organelles by specific transporters (32) and release ROS, which damages DNA and membranes of organelles in the parasite. Different from the cancer cells, the main intermediate accumulated in Plasmodium was CPIII. This is due to the complex haem synthesis pathway in Plasmodium as shown in Supplementary Fig. S1 . PPIX found in the mitochondria may also contribute to the growth inhibition with either Fe 2þ or light irradiation. We have already observed that ALA plus SFC rescued mice infected with Plasmodium yoelii (unpublished result). Furthermore, all of the preclinical data were evaluated by European Medicines Agency, and Phase I clinical study has been completed in 2013. Thus, the clinical study of commercially available ALA plus SFC on malaria is highly feasible.
Supplementary Data
Supplementary Data are available at JB Online. 
